Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals

NCT03306056 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-17

No results posted yet for this study

Summary

The main purpose of this study is to compare the effects of whole-body electromyostimulation versus a conventional low-volume strength-training program, each combined with an individualized, weight-reducing diet, on the cardiometabolic risk profile, muscle strength, body composition, inflammatory markers and subjective health outcomes in overweight individuals at increased cardiometabolic risk.

Conditions

  • Overweight and Obesity
  • Metabolic Syndrome

Interventions

OTHER

Control

Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks

OTHER

Standard Strength Training

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with a standard strength training program: * 5 strength training exercises (chest, upper/lower back, abdominals, legs) * 3 sets per exercise * time-effort per session: \~90 min * 2 training sessions per week * duration of exercise intervention: 12 weeks

OTHER

Low-volume Strength Training

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined a low-volume strength training program: * 5 strength training exercises (chest, upper/lower back, abdominals, legs) * 1 set per exercise * time-effort per session: \~20 min * 2 training sessions per week * duration of exercise intervention: 12 weeks

OTHER

Whole-Body Electromyostimulation (WB-EMS)

Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with WB-EMS: * time-effort per session: \~20 min * duration of exercise intervention: 12 weeks

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Dejan Reljic, Dr. · University Erlangen Nuremberg Medical School

  • Yurdaguel Zopf, Prof. · University Erlangen Nuremberg Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306056 on ClinicalTrials.gov